Glaxosmithkline Pharmaceuticals informs about analyst meet

18 Aug 2017 Evaluate

Glaxosmithkline Pharmaceuticals has informed that pursuant to Regulation 30(6) of the Schedule III, of the Listing Obligations and Disclosure requirements (LODR), Regulations, 2015, the Schedule of Analyst or Institutional Meetings with the Company is on 1st September, 2017 at Mumbai.

The above information is a part of company’s filings submitted to BSE.

Glaxosmithkline Phar Share Price

2596.00 -28.85 (-1.10%)
27-Feb-2026 10:08 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1772.40
Dr. Reddys Lab 1297.10
Cipla 1344.60
Zydus Lifesciences 924.40
Lupin 2309.45
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×